Imagion Biosystems Ltd (IBX) - Total Liabilities

Latest as of December 2025: AU$4.21 Million AUD ≈ $2.98 Million USD

Based on the latest financial reports, Imagion Biosystems Ltd (IBX) has total liabilities worth AU$4.21 Million AUD (≈ $2.98 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Imagion Biosystems Ltd's assets to evaluate the company's liquid asset resilience ratio.

Imagion Biosystems Ltd - Total Liabilities Trend (2014–2025)

This chart illustrates how Imagion Biosystems Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Imagion Biosystems Ltd asset portfolio.

Imagion Biosystems Ltd Competitors by Total Liabilities

The table below lists competitors of Imagion Biosystems Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
iTonic Holdings Ltd. NASDAQ:ITOC	USA	$969.83K
Mercator Limited NSE:MERCATOR	India	Rs24.65 Billion
Pensana Rare Earths Plc LSE:PRE	UK	GBX20.79 Million
RanLOS AB Series B ST:RLOS-B	Sweden	Skr4.90 Million
Atlantic Sapphire As OL:ASA	Norway	Nkr123.89 Million
Andrews Sykes Group plc LSE:ASY	UK	GBX33.85 Million
Prestal Holdings Ltd AU:PTL	Australia	AU$4.34 Million
Infinity Mining Ltd AU:IMI	Australia	AU$392.72K

Liability Composition Analysis (2014–2025)

This chart breaks down Imagion Biosystems Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Imagion Biosystems Ltd (IBX) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.48	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.95	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	2.06	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Imagion Biosystems Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Imagion Biosystems Ltd (2014–2025)

The table below shows the annual total liabilities of Imagion Biosystems Ltd from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	AU$4.21 Million ≈ $2.98 Million	-17.31%
2024-12-31	AU$5.09 Million ≈ $3.60 Million	-39.26%
2023-12-31	AU$8.37 Million ≈ $5.93 Million	+58.06%
2022-12-31	AU$5.30 Million ≈ $3.75 Million	+554.19%
2021-12-31	AU$809.88K ≈ $573.04K	-32.80%
2020-12-31	AU$1.21 Million ≈ $852.71K	-36.52%
2019-12-31	AU$1.90 Million ≈ $1.34 Million	+44.02%
2018-12-31	AU$1.32 Million ≈ $932.73K	+91.39%
2017-12-31	AU$688.77K ≈ $487.35K	+52.39%
2016-12-31	AU$451.99K ≈ $319.81K	-95.32%
2015-12-31	AU$9.65 Million ≈ $6.83 Million	+123.93%
2014-12-31	AU$4.31 Million ≈ $3.05 Million	--

About Imagion Biosystems Ltd

AU:IBX Australia Diagnostics & Research

Market Cap

$2.78 Million

AU$3.92 Million AUD

Market Cap Rank

#29690 Global

#1693 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.01 - AU$0.05

All Time High

AU$8.60